Surgical Innovations


Surgical Innovations' core business is developing instruments for keyhole or minimally invasive surgery. It has been involved in the sector since 1992 and it reversed into Aim-quoted Haemocell in 1998. The Haemocell part of the group is involved in autologous blood transfusion, which is the practice of collecting a patient's blood and re-infusing it into the body. This cuts out the risk of infection from donated blood.

Sector: Health

News blog

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds